newsfilter
← Latest News
PR Newswire·

Avidity Biosciences Announces Expected Record Date for Spin-Off

Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called...